Identification of circ_0058357 as a regulator in non‐small cell lung cancer cells resistant to cisplatin by miR ‐361‐3p/ ABCC1 axis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of circ_0058357 as a regulator in non‐small cell lung cancer cells resistant to cisplatin by
miR
‐361‐3p/
ABCC1
axis
Authors
Keywords
-
Journal
Thoracic Cancer
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-15
DOI
10.1111/1759-7714.14150
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis
- (2021) Youqing Zhong et al. Cancer Biomarkers
- hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis
- (2021) Dongshan Wei et al. Molecular Medicine Reports
- MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway
- (2020) Bin Hua et al. BIOMEDICINE & PHARMACOTHERAPY
- A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer
- (2020) Zihao Pan et al. Molecular Cancer
- CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC)
- (2020) Yongsheng Zhao et al. Cancer Cell International
- Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells
- (2020) Huasong Lu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4
- (2020) Songhui Zhou et al. ONCOLOGY REPORTS
- EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis
- (2020) Chi-Chen Fan et al. Redox Biology
- Circular RNA PRMT5 confers cisplatin‐resistance via miR‐4458/REV3L axis in non‐small‐cell lung cancer
- (2020) Jun Pang et al. CELL BIOLOGY INTERNATIONAL
- CircRNAs in anticancer drug resistance: recent advances and future potential
- (2020) Tianwei Xu et al. Molecular Cancer
- The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer
- (2020) Bianjiang Liu et al. Cell Death & Disease
- MicroRNA-361-3p Inhibit the Progression of Lymphoma by the Wnt/β-Catenin Signaling Pathway
- (2020) Hui Zhou et al. Cancer Management and Research
- Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer
- (2019) Lijian Chen et al. Molecular Cancer
- Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness
- (2019) Michela Terlizzi et al. PHARMACOLOGY & THERAPEUTICS
- The biogenesis, biology and characterization of circular RNAs
- (2019) Lasse S. Kristensen et al. NATURE REVIEWS GENETICS
- LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non‐small cell lung cancer cells via the miR‐361‐3p/FRAT1 axis
- (2019) Xiaomei Li et al. Thoracic Cancer
- LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
- (2018) Hai Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1
- (2018) Haishan Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma
- (2018) Jisheng Hu et al. Cell Death & Disease
- Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway
- (2017) Wei Ma et al. Experimental and Therapeutic Medicine
- Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
- (2016) Antonio Rossi et al. Expert Review of Anticancer Therapy
- MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC
- (2016) Wei Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Functions of MicroRNAs: mRNA Decay and Translational Repression
- (2015) Hiro-oki Iwakawa et al. TRENDS IN CELL BIOLOGY
- MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer
- (2015) Jun Li et al. TUMOR BIOLOGY
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Circular RNAs are a large class of animal RNAs with regulatory potency
- (2013) Sebastian Memczak et al. NATURE
- Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)
- (2011) Qi Wang et al. EXPERIMENTAL LUNG RESEARCH
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search